Scientists have used synthetic antibodies to block cell receptors in the liver that normally bind to glucagon, a hormone involved in increasing the amount of glucose in the blood. The antibodies restored...

The study could lead to the development of more personalized interventions that prevent at-risk individuals from developing type 2 diabetes. People with prediabetes have consistently high blood sugar...